Susan Peers

Title: Susan Peers: Innovator in Adjunctive Therapy

Introduction

Susan Peers is a notable inventor based in Toronto, Canada. She has made significant contributions to the field of adjunctive therapy, particularly through her innovative work involving 25-hydroxyvitamin D. With a total of 4 patents to her name, her research has the potential to impact cancer treatment and management of related conditions.

Latest Patents

One of her latest patents focuses on methods, compositions, and kits for adjunctive therapy using 25-hydroxyvitamin D. This therapy may be administered alongside agents that increase the risk of hypocalcemia, such as cinacalcet or its salts, and/or anticancer agents. The adjunctive therapy is designed to effectively treat and prevent iatrogenic hypocalcemia and secondary hyperparathyroidism. Additionally, it aims to delay cancer progression and the time to a post-treatment skeletal-related event.

Career Highlights

Throughout her career, Susan has worked with reputable companies, including Opko Ireland Global Holdings, Limited and Eirgen Pharma Ltd. Her work in these organizations has allowed her to further her research and develop her innovative therapies.

Collaborations

Susan has collaborated with notable colleagues, including P Martin Petkovich and Joel Z Melnick. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Susan Peers is a pioneering inventor whose work in adjunctive therapy is making strides in the medical field. Her innovative approaches and collaborations continue to pave the way for advancements in cancer treatment and patient care.